These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 33954817)

  • 21. Conjunctival polyploid cells and donor-derived myofibroblasts in ocular GvHD.
    Hallberg D; Stenberg K; Hanson C; Stenevi U; Brune M
    Bone Marrow Transplant; 2016 May; 51(5):692-7. PubMed ID: 26808567
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevalence of extramedullary relapses is higher after allogeneic stem cell transplantation than after chemotherapy in adult patients with acute myeloid leukemia.
    Shimizu H; Saitoh T; Hatsumi N; Takada S; Handa H; Jimbo T; Sakura T; Miyawaki S; Nojima Y
    Leuk Res; 2013 Nov; 37(11):1477-81. PubMed ID: 24054717
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Upfront allogeneic stem-cell transplantation for patients with nonlocalized untreated peripheral T-cell lymphoma: an intention-to-treat analysis from a single center.
    Loirat M; Chevallier P; Leux C; Moreau A; Bossard C; Guillaume T; Gastinne T; Delaunay J; Blin N; Mahé B; Dubruille V; Augeul-Meunier K; Peterlin P; Maisonneuve H; Moreau P; Juge-Morineau N; Jardel H; Mohty M; Moreau P; Le Gouill S
    Ann Oncol; 2015 Feb; 26(2):386-92. PubMed ID: 25392158
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Allogeneic hematopoietic stem cell transplantation in patients with diffuse large B cell lymphoma relapsed after autologous stem cell transplantation: a GITMO study.
    Rigacci L; Puccini B; Dodero A; Iacopino P; Castagna L; Bramanti S; Ciceri F; Fanin R; Rambaldi A; Falda M; Milone G; Guidi S; Martelli MF; Mazza P; Oneto R; Bosi A;
    Ann Hematol; 2012 Jun; 91(6):931-9. PubMed ID: 22245922
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In search of the optimal platform for Post-Allogeneic SCT immunotherapy in relapsed multiple myeloma: a systematic review.
    Oostvogels R; Uniken Venema SM; de Witte M; Raymakers R; Kuball J; Kröger N; Minnema MC
    Bone Marrow Transplant; 2017 Sep; 52(9):1233-1240. PubMed ID: 28692028
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Burden and Needs of Patients with Severe GvHD from the Supportive and Palliative Care Perspective-A Literature Review.
    Wenzel F; Pralong A; Holtick U; Scheid C; Herling M; Simon ST
    Cancers (Basel); 2021 May; 13(11):. PubMed ID: 34070773
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Allogeneic hematopoietic stem cell transplantation for non-Hodgkin's lymphomas: a retrospective analysis of 77 cases.
    Picleanu AM; Novelli S; Monter A; Garcia-Cadenas I; Caballero AC; Martino R; Esquirol A; Briones J; Sierra J
    Ann Hematol; 2017 May; 96(5):787-796. PubMed ID: 28168350
    [TBL] [Abstract][Full Text] [Related]  

  • 28. New approaches in allogenic transplantation in AML.
    Pei X; Huang X
    Semin Hematol; 2019 Apr; 56(2):147-154. PubMed ID: 30926091
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of allogeneic stem cell transplantation on thyroid function.
    Felicetti F; Gatti F; Faraci D; Rosso D; Zavattaro M; Fortunati N; Marinelli L; Leone S; Gill J; Dionisi-Vici M; Dellacasa C; Busca A; Giaccone L; Arvat E; Bruno B; Brignardello E
    J Endocrinol Invest; 2023 Sep; 46(9):1825-1834. PubMed ID: 36884196
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Circulating IL-17 levels during the peri-transplant period as a predictor for early leukemia relapse after myeloablative allogeneic stem cell transplantation.
    Cho BS; Lim JY; Yahng SA; Lee SE; Eom KS; Kim YJ; Chung NG; Jeong DC; Lee S; Kim HJ; Cho SG; Kim DW; Lee JW; Min WS; Park CW; Min CK
    Ann Hematol; 2012 Mar; 91(3):439-48. PubMed ID: 21894475
    [TBL] [Abstract][Full Text] [Related]  

  • 31. What do we need to know about allogeneic hematopoietic stem cell transplant survivors?
    Clark CA; Savani M; Mohty M; Savani BN
    Bone Marrow Transplant; 2016 Aug; 51(8):1025-31. PubMed ID: 27064688
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Unmanipulated haploidentical stem cell transplantation in adults with acute lymphoblastic leukemia: a study on behalf of the Acute Leukemia Working Party of the EBMT.
    Santoro N; Ruggeri A; Labopin M; Bacigalupo A; Ciceri F; Gülbaş Z; Huang H; Afanasyev B; Arcese W; Wu D; Koc Y; Tischer J; Santarone S; Giebel S; Mohty M; Nagler A
    J Hematol Oncol; 2017 May; 10(1):113. PubMed ID: 28558762
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-term outcome after allo-SCT: close follow-up on a large cohort treated with myeloablative regimens.
    Abou-Mourad YR; Lau BC; Barnett MJ; Forrest DL; Hogge DE; Nantel SH; Nevill TJ; Shepherd JD; Smith CA; Song KW; Sutherland HJ; Toze CL; Lavoie JC
    Bone Marrow Transplant; 2010 Feb; 45(2):295-302. PubMed ID: 19597425
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Invasive fungal disease is associated with chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplant: a single center, retrospective study.
    Jin H; Fan Z; Huang F; Chai Y; Xuan L; Lin R; Xu N; Ye J; Sun J; Liu Q
    Infection; 2019 Apr; 47(2):275-284. PubMed ID: 30734248
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Severity of acute gastrointestinal graft-vs-host disease is associated with incidence of bloodstream infection after adult allogeneic hematopoietic stem cell transplantation.
    Modi A; Rybicki L; Majhail NS; Mossad SB
    Transpl Infect Dis; 2020 Feb; 22(1):e13217. PubMed ID: 31769584
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Physical Exercise Training versus Relaxation in Allogeneic stem cell transplantation (PETRA Study) - Rationale and design of a randomized trial to evaluate a yearlong exercise intervention on overall survival and side-effects after allogeneic stem cell transplantation.
    Wiskemann J; Kuehl R; Dreger P; Huber G; Kleindienst N; Ulrich CM; Bohus M
    BMC Cancer; 2015 Sep; 15():619. PubMed ID: 26345187
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The association between the incidence of intestinal graft-vs-host disease and antibiotic use after allogeneic hematopoietic stem cell transplantation.
    Hidaka D; Hayase E; Shiratori S; Hasegawa Y; Ishio T; Tateno T; Okada K; Goto H; Sugita J; Onozawa M; Nakagawa M; Kahata K; Endo T; Hashimoto D; Teshima T
    Clin Transplant; 2018 Sep; 32(9):e13361. PubMed ID: 30054935
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Advantages and limitations of (non-)myeloablative allogeneic stem cell transplantation.
    Huugen D; Schouten HC; Bos GM
    Neth J Med; 2002 May; 60(4):162-9. PubMed ID: 12164394
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Risk Factors and Outcome of Chronic Graft-versus-Host Disease after Allogeneic Stem Cell Transplantation-Results from a Single-Center Observational Study.
    Grube M; Holler E; Weber D; Holler B; Herr W; Wolff D
    Biol Blood Marrow Transplant; 2016 Oct; 22(10):1781-1791. PubMed ID: 27343720
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A single centre experience with allogeneic stem cell transplantation for severe aplastic anaemia in childhood.
    Ladenstein R; Peters C; Minkov M; Emminger-Schmidmeier W; Mann G; Höcker P; Hawliczek R; Rosenmayr A; Fink FM; Niederwieser D; Gadner H
    Klin Padiatr; 1997; 209(4):201-8. PubMed ID: 9293451
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.